This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effectiveness and safety of antipsychotics for the treatment of agitation and psychosis in people with Alzheimer's disease and vascular dementia.
No takes yet. Share an insight, caveat, or question.
Mühlbauer et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: